All Submissions | J. Saba Submissions | Physics Site Links | Home Page

Email: James Saba

GSJ: Received May 21, 22, 2007: http://wbabin.net/saba/saba78.htm

Isolation of Nucleic Acids via Functions of Their Encoded Enzymes

James Saba

This invention teaches materials and methods for screening a library of nucleic acids for those which encode an enzyme which covalently modifies a substrate.

Figures 1A, 1B, & 2 delineate the essential features of the nucleic acid libraries used. For simplicity only one nondesirable library member is shown, yet of course many more are anticipated.

As shown in the figures, and of essence to the invention is that every nucleic acid in a library is associated with a substrate of the desired enzyme. In these examples the substrate is identical for each library member nucleic acid.

The encoding nucleic acid may be any form but is preferably dsDNA or mRNA, and the enzyme product is preferably comprises a protein (although others molecules such a RNA are possible). The substrate may be any molecule, but preferably comprises a protein or nucleic acid sequence.

The first step is expression of the encoded products and importantly this must be done under conditions wherein trans modification of substrates is minimized. There are several ways this could be achieved. One is to perform the reactions in micro, nano, or pico wells (1,2). Another is to use micro, nano pico vessels (3,4). Another is to use a display technology (5,6) such that each nucleic acid is associated with its encoded product. Yet another is to use a method such that a product of a support affixed nucleic acid is bound adjacent to its encoding nucleic acid (7,8,9).

Turning to Figure 1A, after expression of the encoded products, only the first cleaves the substrate, and this cleavage dissociates the affinity tag from its adjacent nucleic acid member. Those library members which do not encode the enzyme activity retain their tags and are abstracted from those which have lost their tags.

Figure 1B is a derivation wherein the library members are affixed to a support. Only that nucleic acid encoding an enzyme which cleaves the substrate, is liberated from the support.

Notice the process in Figures 1A & 1B is ideally suited for isolating nucleases such as restriction enzymes, and proteases.

In Figure 2, the modification is covalent addition of an atomic grouping, such as a phosphate, methyl, actyl, or carbohydrate. The corresponding enzymatic activity would be a kinase, methyl transferase, actyl transferase, and glycosyl transferase. Notice that removal of these and other groups from the substrate could also be the enzymatic activity desired.

Subsequent to reaction, the modified substrate and associated enzyme encoding nucleic acid can be isolated, such as via an antibody to the modification. For example an antibody to phosphotyrosine.

If it should be that the above invention is indeed novel any patentable rights I may have, I freely give away.

It is hoped that others will honor the invention as delineated above and by the following claims.

Claims

1) A library of nucleic acids, at least one but not all members of which is anticipated to encode for an enzyme which covalently modifies a substrate, said substrate being physically associated with each library member nucleic acid.

2) A library of nucleic acids, each member being physically associated with a molecule which is anticipated to function as a substrate of the product encoded by at least one but not all members of the library.

3) The library of claim 1 or 2, wherein the substrate is associated with an affinity tag such that if the substrate is acted upon, the tag is dissociated from the adjacent nucleic acid.

4) The library of claim 1, 2 or 3, wherein the library members are dispersed in micro, nano, pico vessels.

5) The library of claim 1, 2 or 3, wherein the library members are dispersed in micro, nano, pico wells.

6) The library of claim 1, 2 or 3, wherein the library members are affixed on a support.

7) The library of claim 6, wherein the support is in the form of a microarray surface or bead.

8) The library any of claims 1-7, wherein at least one of the encoded proteins is anticipated to function as a endonuclease.

9) The library any of claims 1-7, wherein at least one of the encoded proteins is anticipated to function as a protease.

10) The library any of claim 1-7, wherein at least one of the encoded proteins is anticipated to function as a kinase.

11) The library any of claim 1-7, wherein at least one of the encoded proteins is anticipated to function as a glycosyl transferase.

12) A process for isolating a nucleic acid encoding an enzyme, using any of the libraries described in the prior claims.

13) The process of isolation of claim 12, wherein the enzyme encoded by a nucleic acid preferentially modifies the substrate associated with that nucleic acid.

14) The library any of claims 12 or 13, wherein the enzyme functions as an endonuclease.

15) Claim 14, wherein the endonuclease is a restriction enzyme.

16) The library any of claims 12 or 13, wherein the enzyme functions as a protease.

17) The library any of claims 12 or 13, wherein the enzyme functions as a kinase.

18) The library any of claims 12 or 13, wherein the enzyme functions as a glycosyl transferase.

References

1) Cell-free protein expression and functional assay in nanowell chip
format. Angenendt, et al Anal Chem. 2004 Apr 1;76(7):1844-9

2) Toxin detection by a miniaturized in vitro protein expression array.
Mei, et al Anal Chem. 2005 Sep 1;77(17):5494-500

3) Single-molecule PCR using water-in-oil emulsion.
Nakano, et al J Biotechnol. 2003 Apr 24;102(2):117-24

4) PCR amplification from single DNA molecules on magnetic beads in emulsion: application for high-throughput screening of transcription factor targets.
Kojima, et al Nucleic Acids Res. 2005 Oct 6;33(17):e150

5) Display technologies: application for the discovery of drug and gene delivery agents.
Sergeeva, et al Adv Drug Deliv Rev. 2006 Dec 30;58(15):1622-54. Epub 2006 Oct 1

6) Covalent DNA display as a novel tool for directed evolution of proteins in vitro.
Bertschinger, J & Neri, D Protein Engineering, Design & Selection vol. 17 no. 9

7) Generation of high density protein microarrays by cell-free in situ expression of unpurified PCR products.
Angenendt, et al Mol Cell Proteomics. 2006 Sep;5(9):1658-66. Epub 2006 Jul 5

8) Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method).
He, et al Nucleic Acids Res. 2001 Aug 1;29(15):E73-3.

9) On-chip protein synthesis for making microarrays.
Ramachadran, et al Methods Mol Biol. 2006;328:1-14

10) Solid-phase translation and RNA-protein fusion: a novel approach for folding quality control and direct immobilization of proteins using anchored mRNA.
Biyani, et al Nucleic Acids Res. 2006;34(20):e140. Epub 2006 Oct 24

11) Protein chip fabrication by capture of nascent polypeptides.
Tao, et al Nat Biotechnol. 2006 Oct;24(10):1253-4. Epub 2006 Oct 1

Addendum Jul. 2, 2007
DNA display of biologically active proteins for in vitro protein selection. Yonezawa, et al J Biochem (Tokyo). 2004 Mar;135(3):285-8

Abstract
"In vitro display technologies are powerful tools for screening peptides with desired functions. We previously proposed a DNA display system in which streptavidin-fused peptides are linked with their encoding DNAs via biotin labels in emulsion compartments and successfully applied it to the screening of random peptide libraries. Here we describe its application to functional and folded proteins. By introducing peptide linkers between streptavidin and fused proteins, we achieved highly efficient (>95%) formation of DNA-protein conjugates. Furthermore, we successfully enriched a glutathione-S-transferase gene by a factor of 20-30-fold per round on glutathione-coupled beads. Thus, DNA display should be useful for rapidly screening or evolving proteins based on affinity selection."

Additional Claims

1') Any of the initial claims, wherein the physical association between the substrate and nucleic acid encoding the potential enzyme is covalent.

2') Claim 1' wherein the substrate is a nucleic acid and is contiguous with the nucleic acid encoding the potential enzyme, such that there is at least one contiguous polynucleotide comprising subtrate and potential enzyme.

3) Claim 1' wherein the substrate and nucleic acid encoding the potential enzyme is covalently associated via a linker of no greater than 1000 Daltons.

4') Any of the initial claims, wherein the physical association is noncovalent and direct such that is there is no intervening bulk material such as that of a bead or microchip.

5') Claim 6, wherein the action of an enzyme results in selective liberation of the nucleic acid encoding this enzyme.

-------

Addendum Jul. 10, 2007

This invention should find exceptional use in deriving and optimizing enzymes useful in Synthetic Biology, including enzymes which do conversions not related to those found in nature. Reference

Synthetic Biology (Wikipedia)

For a complete list of articles published by James Saba in the Gen Sci J, please go to http://www.wbabin.net/saba.htm